Paid Schizophrenia Clinical Trials
Schizophrenia clinical trials recruiting. Access new antipsychotic medications. Compensation up to $3,500. Studies for adults with stable or active symptoms.
Compensation
$2,000 - $3,500
Duration
12-52 weeks
Phase
Phase II/III
FDA Regulated
IRB Approved
GCP Certified
Who May Qualify
- Age 18-65 years
- Diagnosis of schizophrenia (DSM-5 criteria)
- Stable antipsychotic regimen for at least 6 weeks
- PANSS score within study-specified range
- Reliable informant or caregiver available
- Outpatient status with stable living situation
Who May Not Qualify
- Current treatment-resistant schizophrenia
- Recent psychiatric hospitalization (within 3 months)
- Active suicidal ideation or behavior
- Substance use disorder (except nicotine)
- Schizoaffective disorder (unless study-specific)
Frequently Asked Questions
What schizophrenia treatments are being studied?
+
Current trials include new antipsychotics with different receptor profiles, long-acting injectable formulations, treatments targeting negative symptoms, and cognitive enhancement therapies.
Will I need to change my current medication?
+
This varies by study. Some trials evaluate new medications alone, while others assess add-on treatments to current antipsychotics. The study team will explain specific requirements.
How often are assessments performed?
+
Studies involve regular psychiatric assessments using standardized scales (PANSS, CGI). Visit frequency varies but is typically weekly initially, then less frequent.
Is a support person required?
+
Many studies prefer or require a reliable informant (family member, caregiver) who can provide additional information about symptoms and functioning.